FOI 5322 – Private Health Insurance (medical Devices And Human Tissue Products) Rules

Written by Claude Haiku 4.5 from the extracted text on 27 Feb 2026. It can miss or misread redacted and scanned pages. Check the source before relying on it.

FOI 5322 releases meeting notices and policy documents concerning conditions imposed on surgical guides and biomodels under the Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No. 2) 2023. The documents involve a January 2024 discussion between Department of Health officials regarding whether to amend, remove, or delay conditions applying to billing codes for surgical guides and biomodels listed under subcategory 07.02 (Plastic and Reconstructive Craniomaxillofacial Implants) on the Prescribed List. The decision sought approval for potential amendments to regulations governing private health insurance benefits for these medical devices, with consideration of publishing a PHI Circular to communicate outcomes. The release includes legislative context regarding the Minister's delegated authority under the Private Health Insurance Act 2007 to establish and modify device listing rules, though substantive details about specific conditions or the ultimate decision are redacted.